Procurement Summary
Country : Czech Republic
Summary : Interferony Beta 1A 2024
Deadline : 29 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 96035295
Document Ref. No. : 059658-2024
Competition : ICB
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : CZK 86129548
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The subject of the public contract is the recurring supply of medicinal products that meet the requirements of SUKL and contain the active substance interferon beta 1A.
Doc Title: Antineoplastic and immunomodulating agents
Contract Type: Supplies
Document Type: Contract notice
Reference Number: VZ-2024-000087
Contract Type: Supplies
Estimated Value: 86129548 - CZK
33652000 - Antineoplastic and immunomodulating agents
Authority Type: National or federal Agency/Office
Type of Procedure: Open procedure
Regulation: European Union, with participation by GPA countries
Bid Type: Submission for all lots
Doc Title: Antineoplastic and immunomodulating agents
Dispatch Date: 2024-01-25
Publish Date: 2024-01-30
Submission Date: 2024-02-29
Documents
Tender Notice